secwatch.observer — SEC 8-K summary
======================================

Issuer:     Oruka Therapeutics, Inc. (ORKA)
CIK:        0000907654
Form:       8-K
Filed at:   2022-10-20T23:59:59+00:00
Accession:  0001564590-22-034773
Event type: other
Sentiment:  neutral
Materiality: 0.20
Item codes: 5.08, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ARCA biopharma sets 2022 annual meeting for Dec 15, record date Oct 25
----------------------------------------------------------------------

- Shareholder proposals/nominations due by Oct 24, 2022 due to meeting being >30 days from prior year.
- Proxy materials expected to be available on or about Nov 4, 2022.
- Record date for voting set as Oct 25, 2022.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/907654/000156459022034773/0001564590-22-034773-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/907654/000156459022034773/abio-8k_20221020.htm
  HTML page:      https://secwatch.observer/filing/0001564590-22-034773

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer